Accreditation/
Credit Designation
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Agios Pharmaceuticals, Inc., and Incyte Corporation.
Not an official event of the 2021 Gastrointestinal Cancers Symposium. Not sponsored, endorsed, or accredited by any of the cosponsoring organizations of the 2021 Gastrointestinal Cancers Symposium.
Medical Crossfire®: Navigating the Advent of Novel Targeted and Immunotherapeutic Approaches in Cholangiocarcinoma
Saturday, January 16, 2021
Live, Interactive Virtual Webcast!
7:00 PM – 9:00 PM EST
Overview
The past year brought new advances for the treatment of cholangiocarcinoma, which is a rare biliary tract malignancy and an aggressive disease. While surgical and locoregional therapies for early-stage disease can yield significant survival improvements, patients with unresectable advanced cholangiocarcinoma have a poor prognosis, with 5-year overall survival rates between 5% and 10%. The use of systemic chemotherapy, biliary stenting, or locoregional treatments have had limited benefit; but novel targets based on understanding of tumor biology and pathophysiology have already shifted treatment paradigms for patients with biomarkers, such as mutated isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2), fibroblast growth factor receptor (FGFR), microsatellite instability-high (MSI-H), and other mutated genes.
The Medical Crossfire®, one of PER’s signature educational formats, is a live webcast program in which a panel of distinguished experts engage in spirted discussions and debates on novel approaches in cholangiocarcinoma. In this activity, 3 key thought leaders explore the latest data regarding unmet needs, advances in pathophysiology, and emerging therapeutic strategies for the management of cholangiocarcinoma across lines of care. This dynamic discussion will help place new developments into clinical context to help you optimize care for your patients with cholangiocarcinoma.
Benefits of Attending
- Learn about novel targets for the treatment of cholangiocarcinoma guided by advancements in understanding pathophysiology and tumor biology
- Obtain expert recommendations for best practices in diagnosing, managing, and treating patients with cholangiocarcinoma
- Gain insights into how the experts handle challenging, real-world clinical cases in cholangiocarcinoma
Acknowledgment of Commercial Support
This activity is supported by educational grants from Agios Pharmaceuticals, Inc., and Incyte Corporation.
Target Audience
This educational program is directed toward all attendees of the 2021 Gastrointestinal Cancers Symposium, including a global audience of medical oncologists, surgical oncologists, radiation oncologists, hepatologists, pathologists, and gastroenterologists interested in the treatment of cholangiocarcinoma. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with cholangiocarcinoma are also invited to participate.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Explain the biologic rationale that has informed recent clinical development of targeted and immunotherapeutic approaches for cholangiocarcinoma
- Integrate key genomic and molecular testing strategies that allow for cholangiocarcinoma tumor characterization and inform decision-making for patients with these tumors
- Apply practice-changing evidence on novel immunotherapies and targeted therapies to clinical scenarios encountered in cholangiocarcinoma management
- Promulgate multidisciplinary approaches to identify and mitigate the impact of treatment-related toxicities in the care of patients with cholangiocarcinoma
Program Chair
Director Emeritus, Liver Cancer Research
Massachusetts General Hospital
Professor of Medicine
Harvard Medical School
Boston, MA
Director, Jiahui International Cancer Center
Shanghai, China
Registration
2 Ways to Register- Online: click here.
- Phone: Please call (888) 949-0045 or (609) 378-3701.
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free
For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
Meeting information is accurate at the time of posting.
Register
You must be logged in to PER to register for this meeting
Or Register for PER now
*Required Fields
.jpg "PER")
